Cargando…

Prevalence of non-diabetic kidney disease and inability of clinical predictors to differentiate it from diabetic kidney disease: results from a prospectively performed renal biopsy study

INTRODUCTION: Renal involvement in type 2 diabetes mellitus (T2DM) may be due to diabetes (diabetic kidney disease (DKD)), causes other than diabetes (non-diabetic kidney disease (NDKD)) or overlap of DKD and NDKD (mixed kidney disease group). Prevalence of NDKD and predictive value of clinical or b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basu, Madhurima, Pulai, Smartya, Neogi, Subhasis, Banerjee, Mainak, Bhattacharyya, Nitai P, Sengupta, Sanghamitra, Mukhopadhyay, Pradip, Ray Chaudhury, Arpita, Ghosh, Sujoy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Pathophysiology/Complications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756194/ https://www.ncbi.nlm.nih.gov/pubmed/36517108 http://dx.doi.org/10.1136/bmjdrc-2022-003058

Ejemplares similares

Abstract 16: Urinary metabolic signatures for differential diagnosis of diabetic and non-diabetic kidney disease
por: Basu, Madhurima, et al.
Publicado: (2022)

Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
por: Bjerre-Christensen, Theis, et al.
Publicado: (2021)

Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy
por: Bian, Xiaohui, et al.
Publicado: (2019)

Early choroidal changes detected by swept-source OCT in type 2 diabetes and their association with diabetic kidney disease
por: Da Silva, Monica Oliveira, et al.
Publicado: (2022)

Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes
por: Vaisar, Tomas, et al.
Publicado: (2018)

Urinary adiponectin as a new diagnostic index for chronic kidney disease due to diabetic nephropathy
por: Yamakado, Shinnosuke, et al.
Publicado: (2019)

Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease
por: Mayeda, Laura, et al.
Publicado: (2020)

Klotho prevents epithelial–mesenchymal transition through Egr-1 downregulation in diabetic kidney disease
por: Li, Yang, et al.
Publicado: (2021)

Combined changes in albuminuria and kidney function and subsequent risk for kidney failure in type 2 diabetes
por: Oshima, Megumi, et al.
Publicado: (2021)

Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease
por: Niewczas, Monika A., et al.
Publicado: (2017)

Two-year longitudinal trajectory patterns of albuminuria and subsequent rates of end-stage kidney disease and all-cause death: a nationwide cohort study of biopsy-proven diabetic kidney disease
por: Yamanouchi, Masayuki, et al.
Publicado: (2021)

Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy
por: Okada, Sadanori, et al.
Publicado: (2020)

Characterization of the renal cortical transcriptome following Roux-en-Y gastric bypass surgery in experimental diabetic kidney disease
por: Nair, Meera, et al.
Publicado: (2020)

Methylation pattern of urinary DNA as a marker of kidney function decline in diabetes
por: Marumo, Takeshi, et al.
Publicado: (2020)

Association of the IgG N-glycome with the course of kidney function in type 2 diabetes
por: Singh, Sunny S, et al.
Publicado: (2020)

Burden of chronic kidney disease and rapid decline in renal function among adults attending a hospital-based diabetes center in Northern Europe
por: Griffin, Tomás P, et al.
Publicado: (2021)

Urine Leucine-Rich α-2 Glycoprotein 1 (LRG1) Predicts the Risk of Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes
por: Liu, Jian-Jun, et al.
Publicado: (2023)

Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS
por: Koshino, Akihiko, et al.
Publicado: (2022)

Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes
por: Baker, Nathaniel L., et al.
Publicado: (2018)

Epidermal Innervation in Type 1 Diabetic Patients: A 2.5-year prospective study after simultaneous pancreas/kidney transplantation
por: Boucek, Petr, et al.
Publicado: (2008)

Cerebral small-vessel disease is associated with the severity of diabetic retinopathy in type 1 diabetes
por: Eriksson, Marika I, et al.
Publicado: (2021)

Presentation, pathology and prognosis of renal disease in type 2 diabetes
por: Tan, Jasmine, et al.
Publicado: (2017)

Circulating Palmitoyl Sphingomyelin Is Associated With Cardiovascular Disease in Individuals With Type 2 Diabetes: Findings From the China Da Qing Diabetes Study
por: Chen, Yanyan, et al.
Publicado: (2022)

Ghrelin attenuates inflammation in diabetic lung disease by TLR4 pathway in vivo and in vitro
por: Liu, Xiao-Yan, et al.
Publicado: (2023)

Coexistent Diabetes Is Associated With the Presence of Adverse Phenotypic Features in Patients With Hypertrophic Cardiomyopathy
por: Jex, Nicholas, et al.
Publicado: (2022)

Central Nervous System Function in Youth With Type 1 Diabetes 12 Years After Disease Onset
por: Northam, Elisabeth A., et al.
Publicado: (2009)

Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study
por: Jaiswal, Mamta, et al.
Publicado: (2017)

Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial
por: Lin, Julie, et al.
Publicado: (2008)

Type 2 Diabetes Partitioned Polygenic Scores Associate With Disease Outcomes in 454,193 Individuals Across 13 Cohorts
por: DiCorpo, Daniel, et al.
Publicado: (2022)

Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
Publicado: (2019)

Association of fasting insulin and C peptide with diabetic retinopathy in Latinos with type 2 diabetes
por: Kuo, Jane Z, et al.
Publicado: (2014)

Association of PAI-1 and Fibrinogen With Diabetic Retinopathy in the Veterans Affairs Diabetes Trial (VADT)
por: Azad, Nasrin, et al.
Publicado: (2014)

Declining trends of diabetic nephropathy, retinopathy and neuropathy with improving diabetes care indicators in Japanese patients with type 2 and type 1 diabetes (JDDM 46)
por: Yokoyama, Hiroki, et al.
Publicado: (2018)

Burden of Urological Complications in Men and Women With Long-standing Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Cohort
por: Wessells, Hunter, et al.
Publicado: (2018)

Oxidation, Type 2 Diabetes, and Coronary Heart Disease: A Complex Interaction: Findings from a population-based study
por: Stranges, Saverio, et al.
Publicado: (2008)

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy
por: Skupien, Jan, et al.
Publicado: (2019)

Insulin Gene Mutations as Cause of Diabetes in Children Negative for Five Type 1 Diabetes Autoantibodies
por: Bonfanti, Riccardo, et al.
Publicado: (2009)

Contrast sensitivity to spatial gratings in moderate and dim light conditions in patients with diabetes in the absence of diabetic retinopathy
por: Safi, Sare, et al.
Publicado: (2017)

Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial
por: Lachin, John M., et al.
Publicado: (2017)

Spatial variations in gut permeability are linked to type 1 diabetes development in non-obese diabetic mice
por: Joesten, William C, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_97ofd55i91gpcjujiuuaoj13rd